GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis

Yasuhiko Kamada, Mikiya Nakatsuka, Kazuo Asagiri, Soichi Noguchi, Toshihiro Habara, Masayo Takata, Takafumi Kudo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Because overproduction of nitric oxide (NO) and peroxynitrite is known to cause tissue injury, the expression of NO synthases (NOS) and generation of peroxynitrite were investigated in adenomyosis. Immunoreactivities to endothelial and inducible NOS demonstrated phase-dependent changes in normal endometrium, and in eutopic endometrium of adenomyosis. However, NOS were expressed throughout the menstrual cycle in ectopic endometrium from the majority of patients with adenomyosis. Nitrotyrosine, a footprint of peroxynitrite, was detected concomitantly with NOS protein. This suggested that high doses of NO and superoxide are produced in the ectopic endometrium, presumably by stimulation with bioactive molecules such as cytokines and growth factors. The expression of NOS and generation of peroxynitrite were markedly reduced by administration of gonadotrophin-releasing hormone agonists (GnRHa). The suppression of serum concentrations of nitrite/nitrate, stable metabolites of NO, by long-term administration of GnRHa was also demonstrated. The suppression of synthesis of NO and/or peroxynitrite may be part of both the therapeutic and adverse effects of GnRHa therapy.

Original languageEnglish
Pages (from-to)2512-2519
Number of pages8
JournalHuman Reproduction
Volume15
Issue number12
Publication statusPublished - 2000

Fingerprint

Adenomyosis
Peroxynitrous Acid
Gonadotropin-Releasing Hormone
Nitric Oxide Synthase
Endometrium
Nitric Oxide
Therapeutic Uses
Menstrual Cycle
Nitrites
Superoxides
Nitrates
Intercellular Signaling Peptides and Proteins
Cytokines
Wounds and Injuries
Serum
Proteins

Keywords

  • Adenomyosis
  • GnRH agonist
  • Nitric oxide
  • Peroxynitrite

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. / Kamada, Yasuhiko; Nakatsuka, Mikiya; Asagiri, Kazuo; Noguchi, Soichi; Habara, Toshihiro; Takata, Masayo; Kudo, Takafumi.

In: Human Reproduction, Vol. 15, No. 12, 2000, p. 2512-2519.

Research output: Contribution to journalArticle

Kamada, Y, Nakatsuka, M, Asagiri, K, Noguchi, S, Habara, T, Takata, M & Kudo, T 2000, 'GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis', Human Reproduction, vol. 15, no. 12, pp. 2512-2519.
Kamada, Yasuhiko ; Nakatsuka, Mikiya ; Asagiri, Kazuo ; Noguchi, Soichi ; Habara, Toshihiro ; Takata, Masayo ; Kudo, Takafumi. / GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. In: Human Reproduction. 2000 ; Vol. 15, No. 12. pp. 2512-2519.
@article{5dcc434da29c4aa4a728f16c76e7f569,
title = "GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis",
abstract = "Because overproduction of nitric oxide (NO) and peroxynitrite is known to cause tissue injury, the expression of NO synthases (NOS) and generation of peroxynitrite were investigated in adenomyosis. Immunoreactivities to endothelial and inducible NOS demonstrated phase-dependent changes in normal endometrium, and in eutopic endometrium of adenomyosis. However, NOS were expressed throughout the menstrual cycle in ectopic endometrium from the majority of patients with adenomyosis. Nitrotyrosine, a footprint of peroxynitrite, was detected concomitantly with NOS protein. This suggested that high doses of NO and superoxide are produced in the ectopic endometrium, presumably by stimulation with bioactive molecules such as cytokines and growth factors. The expression of NOS and generation of peroxynitrite were markedly reduced by administration of gonadotrophin-releasing hormone agonists (GnRHa). The suppression of serum concentrations of nitrite/nitrate, stable metabolites of NO, by long-term administration of GnRHa was also demonstrated. The suppression of synthesis of NO and/or peroxynitrite may be part of both the therapeutic and adverse effects of GnRHa therapy.",
keywords = "Adenomyosis, GnRH agonist, Nitric oxide, Peroxynitrite",
author = "Yasuhiko Kamada and Mikiya Nakatsuka and Kazuo Asagiri and Soichi Noguchi and Toshihiro Habara and Masayo Takata and Takafumi Kudo",
year = "2000",
language = "English",
volume = "15",
pages = "2512--2519",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis

AU - Kamada, Yasuhiko

AU - Nakatsuka, Mikiya

AU - Asagiri, Kazuo

AU - Noguchi, Soichi

AU - Habara, Toshihiro

AU - Takata, Masayo

AU - Kudo, Takafumi

PY - 2000

Y1 - 2000

N2 - Because overproduction of nitric oxide (NO) and peroxynitrite is known to cause tissue injury, the expression of NO synthases (NOS) and generation of peroxynitrite were investigated in adenomyosis. Immunoreactivities to endothelial and inducible NOS demonstrated phase-dependent changes in normal endometrium, and in eutopic endometrium of adenomyosis. However, NOS were expressed throughout the menstrual cycle in ectopic endometrium from the majority of patients with adenomyosis. Nitrotyrosine, a footprint of peroxynitrite, was detected concomitantly with NOS protein. This suggested that high doses of NO and superoxide are produced in the ectopic endometrium, presumably by stimulation with bioactive molecules such as cytokines and growth factors. The expression of NOS and generation of peroxynitrite were markedly reduced by administration of gonadotrophin-releasing hormone agonists (GnRHa). The suppression of serum concentrations of nitrite/nitrate, stable metabolites of NO, by long-term administration of GnRHa was also demonstrated. The suppression of synthesis of NO and/or peroxynitrite may be part of both the therapeutic and adverse effects of GnRHa therapy.

AB - Because overproduction of nitric oxide (NO) and peroxynitrite is known to cause tissue injury, the expression of NO synthases (NOS) and generation of peroxynitrite were investigated in adenomyosis. Immunoreactivities to endothelial and inducible NOS demonstrated phase-dependent changes in normal endometrium, and in eutopic endometrium of adenomyosis. However, NOS were expressed throughout the menstrual cycle in ectopic endometrium from the majority of patients with adenomyosis. Nitrotyrosine, a footprint of peroxynitrite, was detected concomitantly with NOS protein. This suggested that high doses of NO and superoxide are produced in the ectopic endometrium, presumably by stimulation with bioactive molecules such as cytokines and growth factors. The expression of NOS and generation of peroxynitrite were markedly reduced by administration of gonadotrophin-releasing hormone agonists (GnRHa). The suppression of serum concentrations of nitrite/nitrate, stable metabolites of NO, by long-term administration of GnRHa was also demonstrated. The suppression of synthesis of NO and/or peroxynitrite may be part of both the therapeutic and adverse effects of GnRHa therapy.

KW - Adenomyosis

KW - GnRH agonist

KW - Nitric oxide

KW - Peroxynitrite

UR - http://www.scopus.com/inward/record.url?scp=0034531296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034531296&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 2512

EP - 2519

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 12

ER -